Symbol: |
PATE1
|
Description: |
prostate and testis expressed 1 [Source:HGNC Symbol;Acc:24664]
|
Location: |
Chr11:125616188-125619743[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:171
Gene |
Compound |
Gen_sig |
Exp_pattern |
PATE1 |
Uracil, 3-methyl-6-(phenylhydrazino)- |
0.048 |
Up |
PATE1 |
10H-Phenothiazine, 10-(4-chlorobutyl)-1,3,4-trifluoro- 2-nitro- |
0.024 |
Up |
PATE1 |
Benzoic acid, 2-[(4,6-dimethyl-1-oxo-2-indanylidene) methyl]-5-methyl-, methyl ester |
0.035 |
Down |
PATE1 |
Thymine, 1-[1,2-bis(ethoxycarbonyl)ethenyl]- |
0.013 |
Up |
PATE1 |
Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-3-[(ethoxy-carbonyl)methyl]-, trans- |
0.031 |
Up |
PATE1 |
NSC 680418 |
0.005 |
Down |
PATE1 |
5-Phenyl-4-oxo-oxadiazolo(5,4-c)quinolin-3-N-oxide (furoxan) |
0.003 |
Up |
PATE1 |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline,methionine deriv. |
0.02 |
Down |
PATE1 |
NSC 681761 |
0.01 |
Up |
PATE1 |
Propanimidoyl chloride, 2-methyl-N-[[[(2-methylphenyl) amino]carbonyl]oxy]- |
0.025 |
Up |
PATE1 |
Propanimidoyl chloride, N-[[[(3,4-dichlorophenyl)amino] carbonyl]oxy]-2-methyl- |
0.002 |
Up |
PATE1 |
Propanimidoyl chloride, N-[[[(3-chloro-4-fluorophenyl) amino]carbonyl]oxy]-2-methyl- |
0.009 |
Up |
PATE1 |
Propanimidoyl chloride, 2-methyl- N-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]oxy]- |
0.012 |
Up |
PATE1 |
Propanimidoyl chloride, 2-methyl-N-[[[[4-(methoxy- carbonyl)phenyl]amino]carbonyl]oxy]- |
0.007 |
Up |
PATE1 |
Butanimidoyl chloride, N-[[[(3-fluorophenyl)amino] carbonyl]oxy]- |
0.004 |
Up |
Expression pattern: Sensitivity / Resistance
Total:12 Current:7
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:26
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|